We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tullett Prebon | LSE:TLPR | London | Ordinary Share | GB00B1H0DZ51 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 418.30 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
07/6/2013 14:37 | Added a sizable chunk of these to my SIPP this morning. | itchycrack | |
30/5/2013 22:19 | Thanks, Kefta. It supports what I have said over on the IAP thread so I have re-posted there. | hyden | |
30/5/2013 20:06 | from Bloomberg ICAP Plc (IAP) and Tullett Prebon Plc (TLPR), two London-based brokers, led financial stocks higher after they were upgraded by UBS AG on prospects of higher trading volumes. ICAP, the biggest broker of interest-rate swaps between banks, rose as much as 4.6 percent to the highest intraday price in more than 11 months. The shares were up 3.5 percent at 361 pence at 11:20 a.m. It was the best performer in the Stoxx 600 Financial Services Index. Tullett Prebon, an interdealer broker that lines up buyers and sellers of securities for banks, rose as much as 5.7 percent and was up 4.7 percent to 287.9 pence, the highest price since Feb. 25. It was the fifth-best performer among the 600 members of the FTSE All-Share Index. UBS upgraded both ICAP and Tullett Prebon to neutral from sell, citing valuations as well as the likelihood of increased trading volumes. Both companies have underperformed financial stocks by about 35 percent over the past year and exchanges by about 30 percent, the bank said. "This underperformance has been driven by a relative de-rating and weak earnings momentum," UBS said in a note to clients. "We see risks to the upside on both fronts." Interdealer broker trading volumes are up 9 percent in May from April and 6 percent from a year ago, UBS said. The volume of shares traded on the FTSE All-Share Index (ASX) last year was the lowest this century, according to data compiled by Bloomberg. UBS raised its 12-month share price target for ICAP by 11 percent to 340 pence from 305 pence and removed the stock from its least-preferred list. It increased the price target for Tullett Prebon by 12 percent to 280 pence. The bank also raised its earnings estimates for both companies. | kefta | |
30/5/2013 16:37 | Then I think you might be in profit come December. ;-) All imho, of course. | hyden | |
30/5/2013 10:31 | I've had these since they were over £4 each, so I can wait a while yet. | diamond1 | |
30/5/2013 08:47 | ICAP also up today. Sentiment is improving and I think that there's a lot more to come by Year End, if your time horizon is that long? | hyden | |
30/5/2013 08:36 | Nice spike up here today. Don't know why, buys and sells pretty even. Takeover approach? It wouldn't surprise me. | diamond1 | |
22/5/2013 14:06 | Tullett Prebon Plc : Tullett Prebon Informatiom named Best Data Provider at Inside Market Data Awards for third year running | aishah | |
17/5/2013 14:34 | Added a big cfd...... £250,OOO GRAND. So confident of turn around. | mechanical trader | |
17/5/2013 14:31 | Found this browsing guys......... | mechanical trader | |
17/5/2013 10:31 | Tipped as a "Speculative buy" in today's Moneyweek due to seven times projected earnings and 6.4% dividend. | diamond1 | |
16/5/2013 21:34 | Hi M.T I too am keen on this one. gave a "Strong Bull" signal on the 14 May. I find them quite a good guide for entry and exit points. I had been in NG. for the last 18 months but decided to take the profit to buy in here it's been a good run and I will hopefully buy back in NG. at some point. Regards kefta | kefta | |
16/5/2013 12:15 | TLPR far too cheap imo and provides a good dividend yield....... Tullett Prebon ForecastsYear Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield 31-Dec-14 857.23 109.44 39.41p 7.0 1.2 +6% 17.51p 6.5% Forward P/E to 2014 a miserly 7 yes just 7 plus a div yield of 6.5%. Practicaly giving it away. Im adding. | mechanical trader | |
16/5/2013 12:09 | Turned positive for the day. Here we go. | mechanical trader | |
16/5/2013 06:53 | TLPR. SP broken out from a downward trend channel and oscillators turned positive. Should see a gradual rise up to the mid Feb resistance of 305p. Yesterday was a slight blip but remember prices dont go up or down in straight lines. Very bullish on this one. | mechanical trader | |
14/5/2013 14:53 | Daily Breakout just occured.. | mechanical trader | |
14/5/2013 14:51 | Up over 6% now, very nice. | mechanical trader | |
14/5/2013 14:29 | A couple of computerised analytics.... AND | mechanical trader | |
14/5/2013 14:21 | QP Unfortunately I wouldn't go near a biotech these days. Its a shame as it was something of a hobby of mine (I also have a PhD in Biochemistry, hence the moniker). I got my fingers burned too many times - xenova/alizyme/Phyto | dr biotech | |
14/5/2013 13:32 | To state the obvious its doing very well today on the back of ICAPs results - they were slightly better than expected but holding the dividend and giving a more hopeful outlook. They seem to mirror each other quite a lot. | dr biotech | |
14/5/2013 12:27 | 5% rise coming up AISHAH. | mechanical trader |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions